← Leaderboards
Andrew M Lowy
University Of Cincinnati
$7,916,815
Attributed
$11,928,858
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,928,858 · 9
By mechanism
R01$5,055,347 · 2
U01$4,140,202 · 1
R21$1,514,390 · 4
K08$688,875 · 1
U54$530,044 · 1
Top collaborators
- Tannishtha Reya8 shared
- Michael Karin6 shared
- Robert F. Schwabe6 shared
- Paul A Insel2 shared
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMalignant Neoplasm Of PancreasTumorNeoplasm MetastasisGrowthCellsTumor GrowthNew Therapeutic TargetMediatingPancreatic Cancer CellsCancer TherapyMalignant NeoplasmsPancreatic Ductal AdenocarcinomaKras2 GeneIn VivoReceptor SignalingMouse ModelTherapeutic TargetLigandsCancer CellReceptorBiologyPrimary NeoplasmTargeted Treatment
Grant awards (41)
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$1,152,768
U01 · FY2025 · CA
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration$179,042
U54 · FY2025 · CA · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$110,000
U01 · FY2025 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$776,779
U01 · FY2024 · CA
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration$170,683
U54 · FY2024 · CA · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$955,015
U01 · FY2023 · CA
CDK4/6 inhibition: a novel therapeutic strategy for GNAS-mutant gastrointestinal malignancies$217,163
R21 · FY2023 · CA · contact PI
Targeting the MICAL2 signaling axis in pancreatic cancer$217,163
R21 · FY2023 · CA · contact PI
Full Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration$180,319
U54 · FY2023 · CA · contact PI
The effect of cancer cell produced collagen 1 homotrimers on DDR1 signaling activation by microenvironmental collagen 1 fragments.$174,500
U01 · FY2023 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$971,140
U01 · FY2022 · CA
Targeting the MICAL2 signaling axis in pancreatic cancer$184,663
R21 · FY2022 · CA · contact PI
CDK4/6 inhibition: a novel therapeutic strategy for GNAS-mutant gastrointestinal malignancies$184,663
R21 · FY2022 · CA · contact PI
RON Receptor in Pancreatic Cancer Biology and Therapy$306,943
R01 · FY2021 · CA · contact PI
RON Receptor in Pancreatic Cancer Biology and Therapy$306,943
R01 · FY2020 · CA · contact PI
Musashi-mediated control of pancreatic cancer growth and progression$368,133
R01 · FY2019 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy$297,734
R01 · FY2019 · CA · contact PI
Musashi-mediated control of pancreatic cancer growth and progression$95,085
R01 · FY2019 · CA
Musashi-mediated control of pancreatic cancer growth and progression$379,518
R01 · FY2018 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy$306,943
R01 · FY2018 · CA · contact PI
Musashi-mediated control of pancreatic cancer growth and progression$98,025
R01 · FY2018 · CA
Musashi-mediated control of pancreatic cancer growth and progression$379,518
R01 · FY2017 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy$306,943
R01 · FY2017 · CA · contact PI
Musashi-mediated control of pancreatic cancer growth and progression$53,663
R01 · FY2017 · CA
Musashi-mediated control of pancreatic cancer growth and progression$379,518
R01 · FY2016 · CA
Musashi-mediated control of pancreatic cancer growth and progression$379,518
R01 · FY2015 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy$275,576
R01 · FY2015 · CA · contact PI
GPCRs: novel targets in cancer-associated fibroblasts$168,563
R21 · FY2015 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy$275,270
R01 · FY2014 · CA · contact PI
GPCRs: novel targets in cancer-associated fibroblasts$202,275
R21 · FY2014 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy$275,452
R01 · FY2013 · CA · contact PI
RON Receptor in Pancreatic Cancer Biology and Therapy$277,001
R01 · FY2012 · CA · contact PI
RON Receptor in Pancreatic Cancer Biology and Therapy$293,564
R01 · FY2011 · CA · contact PI
Targeting RON Receptor Signaling in Pancreatic Cancer$169,950
R21 · FY2010 · CA · contact PI
Targeting RON Receptor Signaling in Pancreatic Cancer$169,950
R21 · FY2009 · CA · contact PI
Gene Targets of Wnt Signaling in Pancreatic Cancer$68,970
K08 · FY2006 · CA · contact PI
Gene Targets of Wnt Signaling in Pancreatic Cancer$137,943
K08 · FY2005 · CA
Gene Targets of Wnt Signaling in Pancreatic Cancer$137,943
K08 · FY2004 · CA
Gene Targets of Wnt Signaling in Pancreatic Cancer$137,943
K08 · FY2003 · CA
Gene Targets of Wnt Signaling in Pancreatic Cancer$68,973
K08 · FY2002 · CA
Gene Targets of Wnt Signaling in Pancreatic Cancer$137,103
K08 · FY2001 · CA